Voss Chelsea Sierra
Director
PurchaseAlert
- Shares
- 1,753
- Price
- $3.15
- Value
- $5,522
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•26 filings
QCLS
Q/C TECHNOLOGIES, INC.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$5,522
2 distinct insiders
12-month sales
$0.00
0 distinct insiders
Highlighted alerts
3
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get QCLS insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
QCLS overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
26
Raw transactions
Everything returned by the filing
3
Voluntary view
P/S trades after deterministic checks
23
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 77,390
- Price
- $0.00
- Footnotes
- 2
Represents a grant of Restricted Stock. The Restricted Stock was granted to the Reporting Person pursuant to an executive compensation agreement, dated April 13, 2026, by and between the Issuer and the Reporting Person (the "Compensation Agreement") providing for quarterly grants equal to $60,000. The Restricted Stock vested pursuant to the terms of the Compensation Agreement. Represents a grant of Restricted Stock. The Restricted Stock was granted to the Reporting Person pursuant to the Compensation Agreement. The Restricted Stock vested pursuant to the terms of the Compensation Agreement.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
PharmaCyte Biotech, Inc.
10% owner
PurchaseAlert
- Shares
- 889,865
- Price
- —
- Value
- —
PharmaCyte Biotech, Inc.
10% owner
PurchaseAlert
- Shares
- 889,865
- Price
- —
- Value
- —
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.